-
Boehringer Ingelheim and Eli Lilly and Company announce positive top-line pivotal Phase III data results for empagliflozin
- Size:
13 kB
- Last Update:
7.01.2013
-
Annual Press Conference 2011 - Boehringer Ingelheim will present results of the business development 2010 and outlook for 2011 at the Annual Press Conference, 05 April 2010 in the Boehringer Ingelheim Centre in Ingelheim
- Size:
33 kB
- Last Update:
9.01.2013
-
Allan Hillgrove, Boehringer Ingelheim GmbH, Corporate Board Division Pharma Marketing and Sales
- Size:
6 kB
- Last Update:
27.12.2012
-
Boehringer Ingelheim is a family-owned company governed by the board of Managing Directors.
- Size:
7 kB
- Last Update:
3.01.2013
-
Boehringer Ingelheim ranks among the world's leading pharmaceutical companies, focusing on prescription medicines, consumer health care, chemicals, biopharmaceuticals and animal health.
- Size:
1 kB
- Last Update:
4.01.2013
-
Allan Hillgrove, Boehringer Ingelheim GmbH, Corporate Board Division Pharma Marketing and Sales
- Size:
7 kB
- Last Update:
27.12.2012
-
Allan Hillgrove, Boehringer Ingelheim GmbH, Corporate Board Division Pharma Marketing and Sales
- Size:
21 kB
- Last Update:
27.12.2012
-
Allan Hillgrove, Boehringer Ingelheim GmbH, Corporate Board Division Pharma Marketing and Sales
- Size:
2 MB
- Last Update:
27.12.2012
-
Image gallery, Management, Board of Managing Directors Boehringer Ingelheim is a family-owned company governed by the Board of Managing Directors.
- Size:
8 kB
- Last Update:
31.12.2012
-
Use for any other purpose is expressly prohibited, and may result in severe civil and criminal penalties. Violations will be prosecuted. Permission given above does not include the use of the design or layout of the boehringer-ingelheim.
- Size:
11 kB
- Last Update:
31.12.2012